• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Premenstrual Syndrome - Pipeline Review, H1 2012 Product Image

Premenstrual Syndrome - Pipeline Review, H1 2012

  • ID: 2141756
  • May 2012
  • 36 pages
  • Global Markets Direct

Premenstrual Syndrome – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Premenstrual Syndrome - Pipeline Review, H1 2012', provides an overview of the Premenstrual Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Premenstrual Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Premenstrual Syndrome. 'Premenstrual Syndrome - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Premenstrual Syndrome.
- A review of the Premenstrual Syndrome products under development by companies READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Premenstrual Syndrome Overview
Therapeutics Development
An Overview of Pipeline Products for Premenstrual Syndrome
Premenstrual Syndrome Therapeutics under Development by Companies
Premenstrual Syndrome Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Premenstrual Syndrome Therapeutics – Products under Development by Companies
Premenstrual Syndrome Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Premenstrual Syndrome Therapeutics Development
M et P Pharma AG
Umecrine Mood AB
Pherin Pharmaceuticals, Inc.
DEKK-TEC, Inc.
Premenstrual Syndrome – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ProgestoMat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cis-platinum - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CDB-2914 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PH80-PMD - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Dutasteride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
UC1010 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Progestrone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Premenstrual Syndrome Therapeutics – Drug Profile Updates
Premenstrual Syndrome Therapeutics - Dormant Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Premenstrual Syndrome, H1 2012
Products under Development for Premenstrual Syndrome – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
M et P Pharma AG, H1 2012
Umecrine Mood AB, H1 2012
Pherin Pharmaceuticals, Inc., H1 2012
DEKK-TEC, Inc., H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Premenstrual Syndrome Therapeutics – Drug Profile Updates
Premenstrual Syndrome Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Premenstrual Syndrome, H1 2012
Products under Development for Premenstrual Syndrome – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos